Historical record - last NADAC effective date: 11/20/2019
Product Information
RAMIPRIL 5 MG CAPSULE is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.0636 per EA under NDC 00054010829. Its NADAC has been published 314 times since Nov 28, 2013.
FDA first approved this application on Jun 18, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ramipril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054010829
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
11/20/2019
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077900FDA Approved
6/18/2008
TE Code
AB
On Market Since
6/18/2008
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 5 MG CAPSULE has been published 314 times since Nov 28, 2013, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0636 per EA |
|---|---|
| All-time high | $0.1272 (Feb 15, 2017) |
| All-time low | $0.0533 (Apr 17, 2019) |
| Median price | $0.0875 |
| Average price | $0.0849 |
| Largest weekly change | +40.2% (Jan 18, 2017) |
| Weeks tracked | 314 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-34.6%
Last surveyed Nov 27, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RAMIPRIL 5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 5 MG CAPSULE, manufactured by Hikma Pharmaceuticals USA Inc., is $0.0636 per EA (NDC 00054010829), effective Nov 27, 2019.
How has the price of RAMIPRIL 5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 5 MG CAPSULE has declined 34.6%. It has been tracked across 314 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 5 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RAMIPRIL 5 MG CAPSULE has ranged from a low of $0.0533 (Apr 17, 2019) to a high of $0.1272 (Feb 15, 2017), with a median of $0.0875 per EA.
Are there cheaper alternatives to RAMIPRIL 5 MG CAPSULE?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAMIPRIL 5 MG CAPSULE, is $0.0531 per EA — about 16% below RAMIPRIL 5 MG CAPSULE.
Who manufactures RAMIPRIL 5 MG CAPSULE?
RAMIPRIL 5 MG CAPSULE (NDC 00054010829) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.